A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide ... practice rather than a fixed-dose protocol. Among the 750 enrolled ...

Wegovy is a semaglutide drug approved ... s regional campus in Fresno. A weight loss pill would need to be taken daily as opposed to the once-a-week protocol for injectable GLP-1 medications.

Allurion is preparing to enter the US market with a non-surgical weight loss device ... and here we’re talking about one milligram of semaglutide weekly, which is, half of what you would ...

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory trials, with a lower dose of medication.

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

Perspective from Sangeeta Kashyap, MD Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, according to findings from the ...

Aronne noted the sex-based differences: Women vs men lost a mean of 18% vs 11% on semaglutide and 17.8% vs 11% on tirzepatide. “The waist circumference difference mirrors the weight-loss results ...

If tirzepatide can’t be accessed, semaglutide is still a good choice because 15% weight loss, particularly at the population level, is enormous. “Ten years ago, if someone had told you semaglutide was ...

Steve Christo – Corbis/Getty Images Semaglutide is a GLP-1 agonist medication that can assist with diabetes management and weight loss. Experts are interested in understanding additional ...